Sign in

CIK 0000874716

  • Large accelerated filer

IDEXX LABORATORIES INC /DE

Sign in to watch
Ticker
IDXX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010393723
Phone
+1 207-556-0300
Business address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
  1. 4 Open-market sale Executive VP & CFO sold 16,310 shares at an average $629.05 ($10,259,809)
  2. 4 Grant or award Director acquired 10 shares (grant or award)
  3. 4 Grant or award Director acquired 36 shares (grant or award)
  4. 4 Grant or award Director acquired 30 shares (grant or award)
  5. 4 Exercise or conversion Director acquired 1,921 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Senior Vice President acquired 1,256 shares (option exercise)
  8. 4 Open-market sale Senior Vice President sold 2,526 shares at an average $686.21 ($1,733,378)
  9. 4/A Open-market sale Senior Vice President sold 2,000 shares at $558.44 ($1,116,884)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Gift Executive Vice President gave 522 shares (gift)
  12. 4 Open-market sale President & CEO sold 6,000 shares at an average $675.21 ($4,051,262)
  13. 4 Open-market sale Director sold 2,402 shares at $679.58 ($1,632,355)
  14. 4 Exercise or conversion Executive Vice President acquired 1,106 shares (option exercise)
  15. 4 Open-market sale Director sold 3,000 shares at an average $687.87 ($2,063,616)
  16. 4 Shares withheld for taxes Executive VP & CFO gave up 96 shares (to pay taxes)
  17. 4 Shares withheld for taxes President & CEO gave up 179 shares (to pay taxes)
  18. 4 Open-market sale Executive Vice President sold 538 shares at $703.00 ($378,214)
  19. 4 Open-market sale Senior Vice President sold 20,295 shares at an average $698.25 ($14,170,900)
  20. 4 Open-market sale Executive Vice President sold 6,999 shares at an average $691.62 ($4,840,670)

Page 14 of 74 · 1,467 filings